Welcome : Guest

Ohr Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Ohr Pharmaceuticals, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 15 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65050
Price: $750
Company Type: Public
Pages: 16
Date: January 2017
Market Data Tables: 15

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Ophthalmology......2
Table 1: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......2
Table 2: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......3
Glaucoma Drugs......4
Table 3: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......4
Glaucoma......5
Table 4: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......5
Table 5: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......6
Table 6: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......7
Blindness......8
Table 7: Blindness Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Age-Related Macular Degeneration, Cataract, Glaucoma, and Others......8
Breast Cancer......9
Table 8: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......9
Table 9: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......10
Ocular Melanoma......11
Table 10: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......11
Breast Cancer Drugs......12
Table 11: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......12
Diabetic Macular Edema (DME)......13
Table 12: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......13
Table 13: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......14
Ophthalmology Drugs......15
Table 14: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......15
Ophthalmic Steroids......16
Table 15: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......16